Clinical Trial Update: Allogeneic ABCB5-positive Stem Cells for Treatment of CVU [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial of allogeneic ABCB5-positive stem cells for treating chronic venous ulcers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Insufficiency Related Skin Ulcers
• Venous Stasis Ulcers

Drugs mentioned

• ABCB5-positive stem cells

Snippet

Sponsor: RHEACELL GmbH & Co. KG | Conditions: Skin Ulcer Venous Stasis Chronic | Phase 1, Phase 2 | Status: COMPLETED